CytoDyn is a clinical-stage biotechnology company focused on the development and commercialization of leronlimab, an investigational humanized IgG4 monoclonal antibody (mAb) that is designed to bind to C-C chemokine receptor type 5 (CCR5), a protein on the surface of certain immune system cells that... CytoDyn is a clinical-stage biotechnology company focused on the development and commercialization of leronlimab, an investigational humanized IgG4 monoclonal antibody (mAb) that is designed to bind to C-C chemokine receptor type 5 (CCR5), a protein on the surface of certain immune system cells that is believed to play a role in numerous disease processes. CytoDyn is studying leronlimab in multiple therapeutic areas, including infectious disease, cancer, and autoimmune conditions. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.0099 | 6.6 | 0.15 | 0.17 | 0.1471 | 872842 | 0.15998856 | CS |
4 | 0.033 | 26.0047281324 | 0.1269 | 0.209 | 0.1221 | 1940069 | 0.15046296 | CS |
12 | 0.01 | 6.67111407605 | 0.1499 | 0.209 | 0.111 | 2057797 | 0.13841522 | CS |
26 | -0.0101 | -5.94117647059 | 0.17 | 0.315 | 0.111 | 2193219 | 0.15694984 | CS |
52 | -0.0301 | -15.8421052632 | 0.19 | 0.418 | 0.111 | 2391900 | 0.17865527 | CS |
156 | -1.8801 | -92.1617647059 | 2.04 | 2.54 | 0.111 | 2198214 | 0.44565402 | CS |
260 | -0.2152 | -57.3713676353 | 0.3751 | 10.01 | 0.111 | 3029587 | 2.06600048 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.